Healthcare provider profile · identity verified

Susan Mckinney, M.D.

Allopathic & Osteopathic Physicians|Internal Medicine · DALLAS, TX · NPI 1194700542

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Susan Mckinney, M.D. received $109.72 in general payments during 2025 across 3 reported records.

Cleerly, Inc. accounted for 62.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 4 associated products.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$109.72

3 reported records · 3 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Cleerly, Inc.	Unresolved — no canonical attribution shown	$67.97	62.0%	1	2025
Abbott Laboratories	Unresolved — no canonical attribution shown	$24.57	22.4%	1	2025
Echosens North America, Inc.	Unresolved — no canonical attribution shown	$17.18	15.7%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$109.72	3

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
Cleerly Ischemia Normalized: cleerly ischemia	Device	Cleerly, Inc.	$67.97	1	2025
Source payment records 2025-05-16 · Cleerly, Inc. · $67.97 · Open Payments source
Cleerly Labs Normalized: cleerly labs	Device	Cleerly, Inc.	$67.97	1	2025
Source payment records 2025-05-16 · Cleerly, Inc. · $67.97 · Open Payments source
PROCLAIM Normalized: proclaim	Device	Abbott Laboratories	$24.57	1	2025
Source payment records 2025-05-21 · Abbott Laboratories · $24.57 · Open Payments source
Fibroscan Normalized: fibroscan	Device	Echosens North America, Inc.	$17.18	1	2025
Source payment records 2025-05-20 · Echosens North America, Inc. · $17.18 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	517	128
Amlodipine Besylate	Amlodipine Besylate	513	125
Rosuvastatin Calcium	Rosuvastatin Calcium	469	135
Atorvastatin Calcium	Atorvastatin Calcium	416	122
Losartan Potassium	Losartan Potassium	390	106
Lisinopril	Lisinopril	287	80
Metoprolol Succinate	Metoprolol Succinate	232	61
Hydrochlorothiazide	Hydrochlorothiazide	228	60
Alendronate Sodium	Alendronate Sodium	208	68
Escitalopram Oxalate	Escitalopram Oxalate	203	53
Gabapentin	Gabapentin	200	72
Sertraline Hcl	Sertraline Hcl	190	46
Montelukast Sodium	Montelukast Sodium	189	57
Alprazolam	Alprazolam	177	44
Trazodone Hcl	Trazodone Hcl	176	46
Metformin Hcl Er	Metformin Hcl	173	59
Valsartan	Valsartan	168	45
Pantoprazole Sodium	Pantoprazole Sodium	159	52
Metformin Hcl	Metformin Hcl	135	39
Meloxicam	Meloxicam	133	42
Synthroid	Levothyroxine Sodium	131	33
Tramadol Hcl	Tramadol Hcl	131	19
Potassium Chloride	Potassium Chloride	129	48
Ezetimibe	Ezetimibe	127	36
Omeprazole	Omeprazole	120	34
Bupropion Xl	Bupropion Hcl	117	28
Ozempic	Semaglutide	117	22
Zolpidem Tartrate	Zolpidem Tartrate	114	42
Simvastatin	Simvastatin	103	30
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	97	26
Carvedilol	Carvedilol	94	23
Pravastatin Sodium	Pravastatin Sodium	85	23
Tamsulosin Hcl	Tamsulosin Hcl	78	24
Spironolactone	Spironolactone	72	22
Duloxetine Hcl	Duloxetine Hcl	71	16
Furosemide	Furosemide	71	26
Jardiance	Empagliflozin	71	15
Estradiol	Estradiol	70	28
Clopidogrel	Clopidogrel Bisulfate	69	17
Irbesartan	Irbesartan	68	17
Fluoxetine Hcl	Fluoxetine Hcl	67	20
Felodipine Er	Felodipine	65	17
Mirtazapine	Mirtazapine	60	11
Famotidine	Famotidine	59	18
Trulicity	Dulaglutide	59	11
Metoprolol Tartrate	Metoprolol Tartrate	58	20
Eliquis	Apixaban	55	13
Valacyclovir	Valacyclovir Hcl	54	22
Allopurinol	Allopurinol	53	17
Telmisartan	Telmisartan	52	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	50	14
Benazepril Hcl	Benazepril Hcl	49	suppressed
Hydralazine Hcl	Hydralazine Hcl	48	17
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	47	15
Donepezil Hcl	Donepezil Hcl	47	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	47	15
Doxycycline Hyclate	Doxycycline Hyclate	46	39
Esomeprazole Magnesium	Esomeprazole Magnesium	45	11
Fluticasone Propionate	Fluticasone Propionate	45	16
Venlafaxine Hcl Er	Venlafaxine Hcl	44	15
Paxlovid	Nirmatrelvir/Ritonavir	43	41
Xarelto	Rivaroxaban	41	suppressed
Diazepam	Diazepam	40	suppressed
Risedronate Sodium	Risedronate Sodium	40	13
Albuterol Sulfate Hfa	Albuterol Sulfate	39	23
Januvia	Sitagliptin Phosphate	39	suppressed
Mounjaro	Tirzepatide	39	suppressed
Buspirone Hcl	Buspirone Hcl	38	suppressed
Finasteride	Finasteride	38	12
Clonazepam	Clonazepam	37	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	37	11
Citalopram Hbr	Citalopram Hydrobromide	34	suppressed
Lansoprazole	Lansoprazole	33	suppressed
Propranolol Hcl Er	Propranolol Hcl	33	suppressed
Memantine Hcl	Memantine Hcl	32	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	27
Azithromycin	Azithromycin	31	27
Ciprofloxacin Hcl	Ciprofloxacin Hcl	31	29
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	31	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	30	suppressed
Warfarin Sodium	Warfarin Sodium	30	suppressed
Atenolol	Atenolol	29	suppressed
Ondansetron Odt	Ondansetron	28	19
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	27	suppressed
Levetiracetam	Levetiracetam	27	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Acyclovir	Acyclovir	26	15
Ipratropium Bromide	Ipratropium Bromide	26	11
Methylprednisolone	Methylprednisolone	26	25
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Torsemide	Torsemide	26	11
Bisoprolol Fumarate	Bisoprolol Fumarate	25	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	25	suppressed
Verapamil Er	Verapamil Hcl	25	suppressed
Myrbetriq	Mirabegron	24	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	24	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	20
Ramipril	Ramipril	23	suppressed
Ciclopirox	Ciclopirox	22	11
Methotrexate	Methotrexate Sodium	22	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Amoxicillin	Amoxicillin	21	15
Armour Thyroid	Thyroid,pork	21	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Farxiga	Dapagliflozin Propanediol	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Minoxidil	Minoxidil	21	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Lorazepam	Lorazepam	20	suppressed
Methenamine Hippurate	Methenamine Hippurate	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	16
Baclofen	Baclofen	19	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Promethazine Hcl	Promethazine Hcl	19	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	19	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	18	suppressed
Glimepiride	Glimepiride	18	suppressed
Memantine Hcl Er	Memantine Hcl	18	suppressed
Premarin	Estrogens, Conjugated	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Liothyronine Sodium	Liothyronine Sodium	17	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Raloxifene Hcl	Raloxifene Hcl	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Dexlansoprazole Dr	Dexlansoprazole	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Topiramate	Topiramate	14	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Mupirocin	Mupirocin	13	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Primidone	Primidone	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Celecoxib	Celecoxib	12	suppressed
Digoxin	Digoxin	12	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Teriparatide	Teriparatide	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Bumetanide	Bumetanide	11	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Indapamide	Indapamide	11	suppressed
Lurasidone Hcl	Lurasidone Hcl	11	suppressed
Repatha Sureclick	Evolocumab	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Terconazole	Terconazole	11	suppressed
Zoloft	Sertraline Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$109.72 · 3 records	Cleerly, Inc.	Cleerly Ischemia, Cleerly Labs, Fibroscan, PROCLAIM	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error